Access to Cancer Biorepositories-LOI Due September 1
SWOG (formerly the Southwest Oncology Group) is accepting proposals for research projects that will use the specimens and associated clinical data from the huge SELECT/PCPT Biorepository to tackle novel translational research questions. Together the SELECT and PCPT trials randomized more than 53,000 men at risk for prostate cancer to intervention or placebo, generating substantial clinical data related to risk of development of prostate cancer and corresponding biorepositories for molecular epidemiologic and other studies. Visit swog.org or read more…